Literature DB >> 2940462

Long-term results of hepatitis B vaccination in patients on dialysis.

E Benhamou, A M Courouce, A Laplanche, P Jungers, J F Tron, J Crosnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2940462     DOI： 10.1056/NEJM198606263142613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccines.

Authors:  S Li Volti; G Giammanco-Bilancia; G Giammanco; F Mollica
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

2.  Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure.

Authors:  G Pillion; M Chiesa; A Maisin; N Schlegel; C Loirat
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

3.  A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.

Authors:  M C Honorati; A Palareti; P Dolzani; C A Busachi; R Rizzoli; A Facchini
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.

Authors:  Ching-Wen Wang; Li-Chieh Wang; Mei-Hwei Chang; Yen-Hsuan Ni; Huey-Ling Chen; Hong-Yuan Hsu; Ding-Shin Chen
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.

Authors:  R F Schwabe; H Engelmann; S Hess; H Fricke
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.